Bright Minds Biosciences (DRUG) Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Mar 31, 2026: 1 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about DRUG filings

Are insiders buying or selling Bright Minds Biosciences Inc (DRUG) stock?

Neither. Bright Minds Biosciences Inc (DRUG) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded DRUG recently?

None. No member of Congress disclosed a DRUG trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this DRUG smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

14 funds hold a position.

Questions about DRUG filings

Are insiders buying or selling Bright Minds Biosciences Inc (DRUG) stock?

Neither. Bright Minds Biosciences Inc (DRUG) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded DRUG recently?

None. No member of Congress disclosed a DRUG trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this DRUG smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Earnings came in 87.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.17+87.77% beat

-$1.39 expected

Revenue

CAD 0.00

Financial statements: Alpha Vantage

Next report

Estimated report: Dec 22, 2026, in 38 days

Estimates as of Nov 13, 2026

EPS expected

-$1.45

-$2.12 to -$0.61

Last 30 days

5up1down

Analysts raising estimates

Estimate drift

0.09

Change in 30 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 13, 2026	-$0.17est. -$1.39	+87.77%beat	CAD 0.00Alpha Vantage	No year-ago quarter
Mar 31, 2026Reported May 20, 2026	-$1.09est. -$1.26	+13.49%beat	CAD 0.00Alpha Vantage	No year-ago quarter
Dec 31, 2025Reported Feb 12, 2026	-$0.97est. -$1.18	+17.80%beat	CAD 0.00Alpha Vantage	No year-ago quarter
Sep 30, 2025Reported Dec 23, 2025	-$0.57est. -$1.00	+42.86%beat	CAD 0.00Alpha Vantage	No year-ago quarter
Jun 30, 2025Reported Aug 14, 2025	-$0.74est. -$0.88	+15.91%beat	CAD 0.00Alpha Vantage	No year-ago quarter
Mar 31, 2025Reported May 15, 2025	-$0.29est. -$0.39	+25.64%beat	CAD 0.00Alpha Vantage	No year-ago quarter
Dec 31, 2024Reported Feb 13, 2025	$0.01est. -$0.50	+102.00%beat	CAD 0.00Alpha Vantage	No year-ago quarter
Sep 30, 2024Reported Nov 27, 2024	-$0.17est. -$0.60	+71.67%beat	CAD 0.00Alpha Vantage	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $22.84
High: $23.99
Low: $21.63
Prev close: $22.61
52-wk high: $123.75
52-wk low: $17.40
Mkt cap: $231.3M
ROE: -13.6%
Beta: 0.20
P/B: 1.0x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $231M

Valuation

P/B1.02

Quality

Operating margin0.0%
ROE-13.6%
ROA-13.5%

Growth

Beta0.20

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

22oversold

20D volatility

288%annualized

52-week range

$23.45

$17.40$123.75

20D support

$17.40recent floor

20D resistance

$59.71recent ceiling

Returns

5D +23.7%20D -53.8%60D -72.1%

Price vs moving averages

SMA20 -43.0%SMA50 -53.8%SMA200 -66.8%

Volume pace

1.88xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Aug 13, 2026

-$0.17est. -$1.39

+87.77%

CAD 0.00Alpha Vantage

No year-ago quarter

Mar 31, 2026May 20, 2026

-$1.09est. -$1.26

+13.49%

CAD 0.00Alpha Vantage

No year-ago quarter

Dec 31, 2025Feb 12, 2026

-$0.97est. -$1.18

+17.80%

CAD 0.00Alpha Vantage

No year-ago quarter

Sep 30, 2025Dec 23, 2025

-$0.57est. -$1.00

+42.86%

CAD 0.00Alpha Vantage

No year-ago quarter

Jun 30, 2025Aug 14, 2025

-$0.74est. -$0.88

+15.91%

CAD 0.00Alpha Vantage

No year-ago quarter

Mar 31, 2025May 15, 2025

-$0.29est. -$0.39

+25.64%

CAD 0.00Alpha Vantage

No year-ago quarter

Dec 31, 2024Feb 13, 2025

$0.01est. -$0.50

+102.00%

CAD 0.00Alpha Vantage

No year-ago quarter

Sep 30, 2024Nov 27, 2024

-$0.17est. -$0.60

+71.67%

CAD 0.00Alpha Vantage

No year-ago quarter

Bright Minds Biosciences Inc

Smart money at a glance

What do analysts expect?

Questions about DRUG filings

Questions about DRUG filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 87.8% above what analysts expected.

Estimated report: Dec 22, 2026, in 38 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Bright Minds Biosciences Inc

Smart money at a glance

What do analysts expect?

Questions about DRUG filings

Questions about DRUG filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 87.8% above what analysts expected.

Estimated report: Dec 22, 2026, in 38 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Bright Minds Biosciences Inc

Overview

Questions about DRUG filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Bright Minds Biosciences Inc

Overview

Questions about DRUG filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.